- Home
- NICE vs RVMD Comparison
NICE vs RVMD Comparison
Compare NICE & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NICE
- RVMD
- Stock Information
- Founded
- NICE 1986
- RVMD 2014
- Country
- NICE Israel
- RVMD United States
- Employees
- NICE N/A
- RVMD N/A
- Industry
- NICE Computer Software: Prepackaged Software
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NICE Technology
- RVMD Health Care
- Exchange
- NICE Nasdaq
- RVMD Nasdaq
- Market Cap
- NICE 8.6B
- RVMD 7.5B
- IPO Year
- NICE 1996
- RVMD 2020
- Fundamental
- Price
- NICE $132.23
- RVMD $65.92
- Analyst Decision
- NICE Buy
- RVMD Strong Buy
- Analyst Count
- NICE 13
- RVMD 17
- Target Price
- NICE $200.77
- RVMD $77.24
- AVG Volume (30 Days)
- NICE 524.2K
- RVMD 2.4M
- Earning Date
- NICE 11-13-2025
- RVMD 11-05-2025
- Dividend Yield
- NICE N/A
- RVMD N/A
- EPS Growth
- NICE 39.25
- RVMD N/A
- EPS
- NICE 8.36
- RVMD N/A
- Revenue
- NICE $2,838,467,000.00
- RVMD N/A
- Revenue This Year
- NICE $9.20
- RVMD N/A
- Revenue Next Year
- NICE $6.96
- RVMD $537.73
- P/E Ratio
- NICE $14.87
- RVMD N/A
- Revenue Growth
- NICE 11.39
- RVMD N/A
- 52 Week Low
- NICE $122.94
- RVMD $29.17
- 52 Week High
- NICE $200.65
- RVMD $65.98
- Technical
- Relative Strength Index (RSI)
- NICE 49.59
- RVMD 83.83
- Support Level
- NICE $123.69
- RVMD $58.91
- Resistance Level
- NICE $128.47
- RVMD $66.00
- Average True Range (ATR)
- NICE 3.76
- RVMD 2.13
- MACD
- NICE -0.07
- RVMD 0.40
- Stochastic Oscillator
- NICE 57.93
- RVMD 96.89
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.